|
|
Belmont Park hosts inaugural race day medication summit The first "International Summit on Race Day Medication, EIPH and the Racehorse" will take place at Belmont Park in Elmont, New York, on June 13-14. The event is jointly sponsored by the American Association of Equine Practitioners (AAEP), the National Thoroughbred Racing Association (NTRA) and the Racing Medication and Testing Consortium (RMTC). The first day of the summit will be open to anyone who registers to attend. The program for that day will include presentations on the current status of medication issues in racing; an overview of exercise induced pulmonary hemorrhage (EIPH) and its impact upon horse health; management and treatment alternatives for EIPH; and testing issues surrounding treatment for EIPH. These topics will be followed by international panel discussions on regulatory issues surrounding race day medication; veterinary viewpoints on the management of EIPH; and the management of EIPH from a trainer's perspective. Among those scheduled to participate in the summit panel discussions are trainers Kiaran McLaughlin, Graham Motion, John Size and John Gosden (via prerecorded videotape). Participating veterinarians include John McVeigh, Foster Northrop, Rod Daniel, Treve Williams and Rob Pilsworth (via prerecorded videotape). Participating regulators include Denis Egan, Bill Nader, Brian Stewart and Anthony Stirk. An overview of the day's discussions will be presented at the conclusion of the panel discussions. The cost to attend the first day of the summit is $40 per person, with admission including lunch at Belmont Park. There is no charge on Monday for credentialed media. To register for Day 1 of the summit or to apply for a media credential, please contact Wyndee Eastham of the NTRA at 859-422-2603. All attendees must register in advance, and the deadline to register is May 26. The second day of the summit, which will feature a facilitated discussion among RMTC members and invited guests, is closed to the public and media. There will be media availability following the conclusion of Day 2.
 Send this article to a friend
|
|
